• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

B9M:GR

7.925 EUR 0.220 2.86%

As of 13:46:33 ET on 07/11/2014.

Snapshot for BTG PLC (B9M)

Open: 7.697 Day's Range: 7.552 - 7.972 Volume: 0
Previous Close: 7.705 52wk Range: 4.080 - 8.363 1-Yr Rtn: +87.35%

Stock Chart for B9M

No chart data available.
  • B9M:GR 7.925
  • 1D
  • 1M
  • 1Y
7.705
Interactive B9M Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for B9M

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 37.9489
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (03/2015) 0.1660
Est. PEG Ratio -
Market Cap (M EUR) 2,865.62
Shares Outstanding (M) 361.59
30 Day Average Volume 46
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for B9M

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for B9M

BTG plc licenses, develops and commercializes pharmaceuticals and has a pipeline of development programs targeting neurological and other disorders, including varicose veins. The Company also has a substantial and growing revenue stream of milestone payments and royalties from out-licensed products.

Louise MakinCEO/Executive DirectorRolf SoderstromCFO/Executive Director
Peter StratfordCTO:Interventional MedicineGuenter R JanhoferChief Medical Officer/Head:Dev
More Company Profile & Key Executives for B9M

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil